JHCP
PFE icon

Jackson Hole Capital Partners’s Pfizer PFE Stock Holding History

Jackson Hole Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Buy
120,319
+7,252
+6% +$193K 0.56% 55
2025
Q4 		$2.82M Sell
113,067
-9,797
-8% -$247K 0.48% 66
2025
Q3 		$3.13M Sell
122,864
-2,955
-2% -$72.9K 0.54% 59
2025
Q2 		$3.05M Buy
125,819
+14,982
+14% +$349K 0.56% 55
2025
Q1 		$2.81M Buy
110,837
+11,828
+12% +$310K 0.56% 54
2024
Q4 		$2.63M Sell
99,009
-5,007
-5% -$136K 0.53% 50
2024
Q3 		$3.01M Buy
104,016
+2,267
+2% +$66.1K 0.63% 45
2024
Q2 		$2.85M Buy
101,749
+8,674
+9% +$239K 0.62% 47
2024
Q1 		$2.58M Buy
93,075
+2,660
+3% +$73.8K 0.58% 49
2023
Q4 		$2.6M Buy
90,415
+3,342
+4% +$101K 0.66% 39
2023
Q3 		$2.89M Sell
87,073
-1,103
-1% -$39K 0.84% 28
2023
Q2 		$3.23M Sell
88,176
-3,140
-3% -$122K 0.89% 28
2023
Q1 		$3.75M Sell
91,316
-9
-0% -$389 0.98% 24
2022
Q4 		$4.68M Buy
91,325
+2,322
+3% +$111K 1.4% 15
2022
Q3 		$3.9M Buy
89,003
+6,662
+8% +$324K 1.2% 19
2022
Q2 		$4.32M Buy
82,341
+4,719
+6% +$240K 1.35% 15
2022
Q1 		$4.02M Buy
77,622
+3,654
+5% +$190K 1.16% 20
2021
Q4 		$4.37M Sell
73,968
-1,495
-2% -$74.1K 1.37% 17
2021
Q3 		$3.25M Buy
75,463
+5,227
+7% +$232K 1.05% 24
2021
Q2 		$2.75M Buy
70,236
+5,511
+9% +$214K 0.95% 33
2021
Q1 		$2.35M Buy
64,725
+6,665
+11% +$237K 0.97% 27
2020
Q4 		$2.14M Buy
58,060
+3,283
+6% +$120K 0.97% 30
2020
Q3 		$1.91M Buy
54,777
+695
+1% +$24.4K 1% 24
2020
Q2 		$1.68M Buy
54,082
+4,884
+10% +$166K 1.02% 30
2020
Q1 		$1.52M Buy
49,198
+520
+1% +$17.7K 1.14% 25
2019
Q4 		$1.81M Hold
48,678
– – 0.99% 28
2019
Q3 		$1.66M Buy
48,678
+6,037
+14% +$220K 0.94% 30
2019
Q2 		$1.75M Buy
42,641
+2,812
+7% +$112K 1.09% 18
2019
Q1 		$1.6M Buy
39,829
+1,665
+4% +$66.7K 1.42% 16
2018
Q4 		$1.58M Buy
+38,164
New +$1.58M 1.67% 14

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jackson Hole Capital Partners's PFE Position: Q1 2026 in Review

Jackson Hole Capital Partners increased its Pfizer (PFE) stake by 6.4% in Q1 2026, buying an estimated $193K and bringing the position to 120,319 shares worth $3.38M. The position accounts for 0.56% of the portfolio, ranked #55.

Jackson Hole Capital Partners first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.68M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Jackson Hole Capital Partners held 120,319 shares of Pfizer worth $3.38M as of Q1 2026.
  • Jackson Hole Capital Partners bought 7,252 Pfizer shares in Q1 2026, an estimated $193K.
  • Pfizer made up 0.56% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #55 holding.
  • Jackson Hole Capital Partners first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Jackson Hole Capital Partners's Pfizer position peaked at $4.68M in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.